KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 118 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.60 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,077 | -70.1% | 21,699 | -60.1% | 0.00% | -66.7% |
Q2 2023 | $97,371 | -48.1% | 54,397 | +12.9% | 0.01% | -53.8% |
Q1 2023 | $187,486 | +247.2% | 48,197 | +299.9% | 0.01% | +160.0% |
Q2 2022 | $54,000 | -86.2% | 12,053 | -77.4% | 0.01% | -85.3% |
Q1 2022 | $392,000 | +905.1% | 53,300 | +773.8% | 0.03% | +1033.3% |
Q4 2021 | $39,000 | +3800.0% | 6,100 | +1880.5% | 0.00% | – |
Q3 2021 | $1,000 | -96.6% | 308 | -84.9% | 0.00% | -100.0% |
Q3 2020 | $29,000 | -86.6% | 2,039 | -82.0% | 0.00% | -85.7% |
Q4 2019 | $216,000 | +200.0% | 11,300 | +167.0% | 0.02% | +320.0% |
Q3 2018 | $72,000 | +3500.0% | 4,232 | +1497.0% | 0.01% | – |
Q3 2015 | $2,000 | -96.1% | 265 | -75.9% | 0.00% | -100.0% |
Q2 2014 | $51,000 | – | 1,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |